London, 26 June 2023: Leading global pharmaceutical company GSK plc has made an announcement stating that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has provided a favourable opinion recommending the authorization of daprodustat. The recommendation is specifically for the treatment of symptomatic anaemia
The population explosion adds to the worries of our planet, already grappling with so much. On one side, while it contributes profusely to carbon emissions, it causes more pressure on the energy sources, on the other. On top of it, the food scarcity that it has resulted in is a
June 15, 2023: Scientists have created an insulin derived from plants, specifically lettuce, which is claimed to be a more affordable and secure substitute for regular hormone injections. A recent study led by Henry Daniell from Penn's School of Dental Medicine, published in the journal Biomaterials, highlights the
London, June 15, 2023: The Health Minister of Saudi Arabia, Fahad Al-Jalajel and the Secretary of State for Health and Social Care in the UK, Steve Barcly have officially entered into a Memorandum of Cooperation (MoC) between their respective ministries, solidifying a formal agreement for joint efforts to strengthen collaboration
12 June 2023: Syncona Ltd has introduced its third gene therapy company Beacon Therapeutics Holdings Ltd. Beacon Therapeutics will bring together two preclinical ophthalmologic programs owned by Syncona with Applied Genetic Technologies Corp's (AGTC's) advanced X-linked retinitis pigmentosa (XLRP) program. Syncona has allocated £75 million to